| 1. | | Recruiting | Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects with Crohn’s Disease
Condition: Crohn's Disease |
| 2. | | Completed | Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Patients Following Failure with Kaletra (lopinavir/ritonavir) as Their Second Protease Inhibitor.
Condition: HIV Infections |
| 3. | | Completed | Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Patients Following Failure with Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART
Condition: HIV Infections |
| 4. | | Completed | A Comparison of Two Types of Injected Nutritional Supplements in Patients with AIDS and Pneumocystis carinii Pneumonia (PCP)
Condition: HIV Infections |
| 5. | | No longer recruiting | Depakote ER plus an atypical antipsychotic vs. an atypical antipsychotic alone in the treatment of schizophrenia
Condition: Schizophrenia |
| 6. | | Terminated | Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects during the Maintenance Phase of Bipolar Illness
Condition: Bipolar Disorder |
| 7. | | Completed | Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients
Condition: HIV Infections |
| 8. | | Recruiting | Evaluate the Survival Benefits of Zemplar versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis
Condition: End-Stage Kidney Disease |
| 9. | | Recruiting | Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.
Condition: Heart Failure, Congestive |
| 10. | | No longer recruiting | Homocysteine Study (HOST)
Conditions: Renal Failure; End Stage Renal Disease |
| 11. | | Recruiting | Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis |
| 12. | | Completed | An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder
Condition: Bipolar Disorder |
| 13. | | Recruiting | Levosimendan versus Dobutamine in Shock Patients
Conditions: Cardiogenic Shock; Septic Shock |
| 14. | | Completed | Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent
Condition: HIV Infections |
| 15. | | No longer recruiting | Lopinavir/Ritonavir in Combination with Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects
Condition: HIV Infections |
| 16. | | Recruiting | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy, and Pharmacokinetics of the Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Rheumatoid Arthritis
Condition: Arthritis, Juvenile Rheumatoid |
| 17. | | Recruiting | An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents
Condition: Bipolar Disorder |
| 18. | | Completed | Phase I Safety Study of anti-HIV Immune Serum Globulin (Human)
Condition: HIV Infections |
| 19. | | No longer recruiting | A Phase II Randomized Study Evaluating the Safety and Efficacy of ABT-510 in Subjects with Locally Advanced or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma, Soft Tissue |
| 20. | | Completed | A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. avium Complex (MAC) Infections in Patients With AIDS
Conditions: Mycobacterium avium-intracellulare Infection; HIV Infections |
| 21. | | Recruiting | A Phase II Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects with Refractory Lymphoma
Conditions: Lymphoma, Non-Hodgkin; Hodgkin's Lymphoma |
| 22. | | Completed | A Phase II Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects with Crohn's Disease
Condition: Crohn's Disease |
| 23. | | Completed | A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients without Previous Anti-HIV Drug Therapy
Condition: HIV Infections |
| 24. | | Completed | A Phase III, Randomized Study of Atrasentan in Men with Metastatic, Hormone-Refractory Prostate Cancer
Condition: Prostate Cancer |
| 25. | | Completed | Remission in Subjects with Crohn's Disease
Condition: Crohn's Disease |
| 26. | | No longer recruiting | Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects with Non-Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung |
| 27. | | Completed | The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium avium Complex (MAC) Infection in HIV-Infected Patients
Conditions: Mycobacterium avium-intracellulare Infection; HIV Infections |
| 28. | | Completed | The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used with or without Clofazimine in the Treatment of MAC in Patients with AIDS
Conditions: Mycobacterium avium-intracellulare Infection; HIV Infections |
| 29. | | Completed | The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children with AIDS
Conditions: Mycobacterium avium-intracellulare Infection; HIV Infections |
| 30. | | Terminated | The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants
Condition: HIV Infections |
| 31. | | Completed | The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma
Conditions: Sarcoma, Kaposi; HIV Infections |
| 32. | | Recruiting | Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects with Multiple Sclerosis (MS)
Conditions: Multiple Sclerosis; Multiple Sclerosis, Relapsing Remitting; Multiple Sclerosis, Secondary Progressive |
| 33. | | Completed | Safety and Effectiveness of Zemplar Injection in decreasing iPTH levels in pediatric ESRD subjects on hemodialysis
Conditions: Secondary Hyperparathyroidism; End Stage Renal Disease |
| 34. | | No longer recruiting | Safety and Efficacy of ABT-510 in Subjects with Advanced Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell |
| 35. | | No longer recruiting | Safety and Efficacy of Atrasentan in Men with Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure
Condition: Prostatic Neoplasms |
| 36. | | Completed | Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (daily dosing)
Condition: Renal Insufficiency, Chronic |
| 37. | | Completed | Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three times weekly)
Condition: Renal Insufficiency, Chronic |
| 38. | | Completed | Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three times weekly)
Condition: Renal Insufficiency, Chronic |
| 39. | | No longer recruiting | A simplified Kaletra® (lopinavir/ritonavir)-based therapy versus a Sustiva® (efavirenz)-based standard of care in previously non-treated HIV-infected subjects
Condition: HIV Infections |
| 40. | | Completed | A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors
Condition: HIV Infections |
| 41. | | No longer recruiting | A Study of ABT-378/Ritonavir in HIV-Infected Patients
Condition: HIV Infections |
| 42. | | Recruiting | A Study of ABT-751 in Patients With Colorectal Cancer
Condition: Colorectal Cancer |
| 43. | | Recruiting | A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer
Condition: Non-small cell lung cancer |
| 44. | | Recruiting | A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.
Condition: Breast Cancer |
| 45. | | Completed | A Study of ABT-751 in Patients With Renal Cell Cancer
Condition: Renal Cell Cancer |
| 46. | | No longer recruiting | Study of Atrasentan in Men with Non-Metastatic, Hormone-Refractory Prostate Cancer
Condition: Prostatic Neoplasms |
| 47. | | Completed | Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects with Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis |
| 48. | | Completed | Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects
Condition: HIV Infections |
| 49. | | Completed | A Study of Ritonavir (ABT-538) When Used with Nelfinavir in HIV-Infected Patients
Condition: HIV Infections |
| 50. | | Completed | A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients
Condition: HIV Infections |
